Literature DB >> 20109597

Left ventricular noncompaction.

Radha J Sarma1, Amar Chana, Uri Elkayam.   

Abstract

According to the World Health Organization classification of cardiomyopathies, left ventricular noncompaction is still an unclassified cardiomyopathy. In 2006, the American Heart Association classified this entity as a primary cardiomyopathy of genetic origin. In 2008, the European Society of Cardiology updated the classification scheme similar to the World Health Organization classification. At present, there is no consensus on the diagnostic criteria, and diagnosis is based on the morphologic features identified by cardiac imaging studies or at autopsy. Due to lack of standardization of the diagnostic criteria and little awareness of this condition among clinicians, the true prevalence of this disease is not clear. There is no specific therapy for this condition. However, it seems prognosis is much better than initially reported. The current status of diagnosis, prognosis, and management of isolated noncompaction in adults is discussed in this review.

Entities:  

Mesh:

Year:  2010        PMID: 20109597     DOI: 10.1016/j.pcad.2009.11.001

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  31 in total

1.  Cardioembolic stroke due to isolated left ventricular non-compaction.

Authors:  Yohei Asakawa; Hidehiro Takekawa; Keisuke Suzuki; Shigeru Toyoda; Teruo Inoue; Koichi Hirata
Journal:  Neurol Sci       Date:  2011-12-31       Impact factor: 3.307

2.  Ethnic differences in ventricular hypertrabeculation on cardiac MRI in elite football players.

Authors:  T Luijkx; M J Cramer; A Zaidi; R Rienks; P J Senden; S Sharma; F J van Hellemondt; C F Buckens; W P Mali; B K Velthuis
Journal:  Neth Heart J       Date:  2012-10       Impact factor: 2.380

3.  Neuromuscular comorbidity, heart failure, and atrial fibrillation as prognostic factors in left ventricular hypertrabeculation/noncompaction.

Authors:  Claudia Stöllberger; Gerhard Blazek; Martin Gessner; Katharina Bichler; Christian Wegner; Josef Finsterer
Journal:  Herz       Date:  2015-05-05       Impact factor: 1.443

4.  Improvement in systolic function in left ventricular non-compaction cardiomyopathy: A case report.

Authors:  Tiffany Lin; Michael Wesley Milks; Bharathi Upadhya; William Gregory Hundley; Richard Brandon Stacey
Journal:  J Cardiol Cases       Date:  2014-09-06

5.  Echocardiography in the diagnosis of apical non-compaction associated with congenital heart diseases.

Authors:  I B Vijayalakshmi; Chitra Narasimhan; Anuspandana Mahapatra; C N Manjunath
Journal:  J Echocardiogr       Date:  2013-12-31

6.  Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure.

Authors:  Qiong Qiu; Yang-xin Chen; Jing-ting Mai; Wo-liang Yuan; Yu-lin Wei; Ying-mei Liu; Li Yang; Jing-Feng Wang
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-13       Impact factor: 2.357

7.  Sudden death due to biventricular non-compaction cardiomyopathy in a 14-year-old.

Authors:  Paul J Cohen; Joseph A Prahlow
Journal:  Forensic Sci Med Pathol       Date:  2014-12-31       Impact factor: 2.007

8.  Isolated right ventricular noncompaction in a newborn.

Authors:  Ahmet Sert; Ebru Aypar; Eyup Aslan; Dursun Odabas
Journal:  Pediatr Cardiol       Date:  2012-07-19       Impact factor: 1.655

Review 9.  Extracellular matrix and heart development.

Authors:  Marie Lockhart; Elaine Wirrig; Aimee Phelps; Andy Wessels
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-25

10.  Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy.

Authors:  Guillermo Luxán; Jesús C Casanova; Beatriz Martínez-Poveda; Belén Prados; Gaetano D'Amato; Donal MacGrogan; Alvaro Gonzalez-Rajal; David Dobarro; Carlos Torroja; Fernando Martinez; José Luis Izquierdo-García; Leticia Fernández-Friera; María Sabater-Molina; Young-Y Kong; Gonzalo Pizarro; Borja Ibañez; Constancio Medrano; Pablo García-Pavía; Juan R Gimeno; Lorenzo Monserrat; Luis J Jiménez-Borreguero; José Luis de la Pompa
Journal:  Nat Med       Date:  2013-01-13       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.